CLINICAL TRIALS WITH RADIOLABELED ANTIBODIES

放射性标记抗体的临床试验

基本信息

项目摘要

Accurate detection and anatomic localization of both primary and metastatic lesions remains one of the major problems in the management of most human carcinomas. We have recently initiated clinical trials at the NIH Clinical Center to detect and localize colorectal carcinoma lesions using radiolabeled MAb B72.3. Parameters that will be systematically investigated concerning both the efficiency of MAb localization and the efficiency of gamma scanning of carcinoma lesions include: (a) effect of MAb dose and specific activity of radionuclide coupled MAb; (b) comparison of the use of intact IgG, F(ab')2, and Fab'; (c) choice of radionuclide; (d) route of inoculation; (e) size, location, and other inherent properties of the tumor mass such as antigen content; (f) the presence of circulating antigen; (g) the presence and/or absence of human anti-murine Ig antibodies; (h) metabolism of MAb and fragments; (i) combiantions of MAbs. It is hoped that these studies will also aid in establishing a rational basis for the subsequent therapeutic use of a particular MAb, either coupled to toxins, via effector cell-mediated or complement-mediated mechanisms, or using MAbs radiolabeled with one of a variety of isotopes. This latter goal can be accomplished by direct analyses of biopsy material (both tumor and normal tissues) from patients receiving radiolabeled MAb to define the "radiolocalization index" or potential "therapeutic index" (i.e., the ratio of the amount of MAb bound [via cpm] per gram of tumor tissue to that bound per gram of normal tissues).
原发和转移的准确检测和解剖定位

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

J SCHLOM其他文献

J SCHLOM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('J SCHLOM', 18)}}的其他基金

DESIGN & DEVELOPMENT OF RECOMBINANT VACCINES FOR CANCER IMMUNOTHERAPY
设计
  • 批准号:
    6100774
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
DESIGN & DEVELOPMENT OF RECOMBINANT VACCINES FOR CANCER IMMUNOTHERAPY
设计
  • 批准号:
    6160874
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CLINICAL TRIALS WITH RADIOLABELED ANTIBODIES
放射性标记抗体的临床试验
  • 批准号:
    3939339
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MONOCLONAL ANTIBODIES DEFINE CARCINOMA ASSOCIATED AND DIFFERENTIATION ANTIGENS
单克隆抗体定义癌相关抗原和分化抗原
  • 批准号:
    3939256
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MONOCLONAL ANTIBODIES DEFINE CARCINOMA ASSOCIATED AND DIFFERENTIATION ANTIGENS
单克隆抗体定义癌相关抗原和分化抗原
  • 批准号:
    3916281
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MONOCLONAL ANTIBODIES DEFINE CARCINOMA ASSOCIATED AND DIFFERENTIATION ANTIGENS
单克隆抗体定义癌相关抗原和分化抗原
  • 批准号:
    3813325
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ANTI-CARCINOMA MONOCLONAL ANTIBODIES CLINICAL TRIALS
抗癌单克隆抗体临床试验
  • 批准号:
    3813404
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ANTI-CARCINOMA MONOCLONAL ANTIBODIES CLINICAL TRIALS
抗癌单克隆抗体临床试验
  • 批准号:
    3808558
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CLINICAL UTILITY OF MONOCLONAL ANTIBODIES AND RECOMBINANT IMMUNOGLOBULIN FORMS
单克隆抗体和重组免疫球蛋白形式的临床应用
  • 批准号:
    5200920
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
LOCALIZATION AND THERAPY USING LABELED MONOCLONAL ANTIBODIES--MODEL SYSTEMS
使用标记的单克隆抗体进行定位和治疗——模型系统
  • 批准号:
    3796502
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

'What then do I love, when I love my God?': Divine personae and the human subject in the devotional culture of late fourteenth-century Yorkshire.
“当我爱我的上帝时,我爱什么呢?”:十四世纪末约克郡虔诚文化中的神圣人物和人类主体。
  • 批准号:
    2742225
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Studentship
Human Subject Core
人类主体核心
  • 批准号:
    10574519
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Human Subject Core
人类主体核心
  • 批准号:
    10596985
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Human Subject Core
人类主体核心
  • 批准号:
    10360441
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Study for the development of ethical fuidelines and review methodology for non-medical human subject research at Universities
大学非医学人类课题研究的道德准则发展和审查方法研究
  • 批准号:
    21K13658
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Human Subject Core
人类主体核心
  • 批准号:
    10379916
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Human Subject Core
人类主体核心
  • 批准号:
    10091061
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Characterizing and Restoring Joint Motion in Patients with Hallux Rigidus: Human Subject Testing
拇强直患者的关节运动特征和恢复:人体测试
  • 批准号:
    10710384
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Characterizing and Restoring Joint Motion in Patients with Hallux Rigidus: Human Subject Testing
拇强直患者的关节运动特征和恢复:人体测试
  • 批准号:
    10262929
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Understanding Gender Bias in Human Subject Sampling in HCI Research
了解人机交互研究中人类受试者抽样中的性别偏见
  • 批准号:
    542746-2019
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了